Lista de obras -

7th Drug hypersensitivity meeting: part two.

artículo científico publicado en 2016

AdDRESSing T-cell responses to antituberculous drugs.

artículo científico publicado en 2017

Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions

scientific article published on 22 August 2018

Bone allograft non-union is related to excessive osteoclastic bone resorption: a sheep model study

artículo científico publicado en 2006

Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis.

artículo científico publicado en 2016

Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

artículo científico publicado en 2014

HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity.

artículo científico publicado en 2014

HLA and pharmacogenetics of drug hypersensitivity.

artículo científico publicado en 2012

HLA class I-drug-T-cell receptor interactions in SJS/TEN.

artículo científico publicado en 2014

HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms

artículo científico publicado en 2019

HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

artículo científico publicado en 2017

Improving the Effectiveness of Penicillin Allergy De-labeling.

artículo científico publicado en 2015

Individualization of antiretroviral therapy ⬇️

artículo científico publicado el 29 de diciembre de 2011

SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

artículo científico publicado en 2018

Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

artículo científico publicado en 2017

Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles

artículo científico publicado en 2017

T cell-mediated hypersensitivity reactions to drugs

artículo científico publicado en 2014

The Combined Utility of Ex vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In vivo Skin Testing in Patients With Antibiotic-Associated Severe Cutaneous Adverse Reactions.

artículo científico publicado en 2017

Lista de obras de

7th Drug hypersensitivity meeting: part two.

AdDRESSing T-cell responses to antituberculous drugs.

Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions

Bone allograft non-union is related to excessive osteoclastic bone resorption: a sheep model study

Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis.

Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity.

HLA and pharmacogenetics of drug hypersensitivity.

HLA class I-drug-T-cell receptor interactions in SJS/TEN.

HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms

HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

Improving the Effectiveness of Penicillin Allergy De-labeling.

Individualization of antiretroviral therapy ⬇️

SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles

T cell-mediated hypersensitivity reactions to drugs

The Combined Utility of Ex vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In vivo Skin Testing in Patients With Antibiotic-Associated Severe Cutaneous Adverse Reactions.